Literature DB >> 12172829

Herpes zoster by reactivated vaccine varicella zoster virus in a healthy child.

Barbara Uebe1, Andreas Sauerbrei, Stefan Burdach, Gerd Horneff.   

Abstract

UNLABELLED: Varicella can be prevented by vaccination using the live-attenuated Oka vaccine strain of varicella zoster virus (VZV). Only mild breakthrough disease has been reported in seronegative vaccinees when exposed to the wild-type virus. The latent varicella vaccine virus has rarely caused herpes zoster in childhood and adolescence. We report a healthy 2-year-old girl who developed an impressive herpes zoster infection 16 months after vaccination, localised in three cervical dermatoma. As causative virus, VZV vaccine strain was identified by polymerase chain reaction and analysis of restriction fragment length polymorphisms of the amplified products.
CONCLUSION: vaccine varicella zoster virus can occasionally reactivate in healthy children and present as herpes zoster. Virus characterisation is necessary to identify the strain and provide information on the incidence of occurrence.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12172829     DOI: 10.1007/s00431-002-0981-1

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  15 in total

1.  Monitoring prevalence of varicella-zoster virus clades in Germany.

Authors:  A Sauerbrei; J Stefanski; A Philipps; A Krumbholz; R Zell; P Wutzler
Journal:  Med Microbiol Immunol       Date:  2010-10-31       Impact factor: 3.402

2.  Role of the JNK Pathway in Varicella-Zoster Virus Lytic Infection and Reactivation.

Authors:  Sravya Kurapati; Tomohiko Sadaoka; Labchan Rajbhandari; Balaji Jagdish; Priya Shukla; Mir A Ali; Yong Jun Kim; Gabsang Lee; Jeffrey I Cohen; Arun Venkatesan
Journal:  J Virol       Date:  2017-08-10       Impact factor: 5.103

Review 3.  Diagnosis, antiviral therapy, and prophylaxis of varicella-zoster virus infections.

Authors:  A Sauerbrei
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-02-12       Impact factor: 3.267

Review 4.  Varicella zoster virus vaccines: potential complications and possible improvements.

Authors:  Benjamin Silver; Hua Zhu
Journal:  Virol Sin       Date:  2014-10-24       Impact factor: 4.327

5.  Genetic profile of an Oka varicella vaccine virus variant isolated from an infant with zoster.

Authors:  Andreas Sauerbrei; Elena Rubtcova; Peter Wutzler; D Scott Schmid; Vladimir N Loparev
Journal:  J Clin Microbiol       Date:  2004-12       Impact factor: 5.948

6.  The varicella-zoster virus portal protein is essential for cleavage and packaging of viral DNA.

Authors:  Melissa A Visalli; Brittany L House; Anca Selariu; Hua Zhu; Robert J Visalli
Journal:  J Virol       Date:  2014-05-07       Impact factor: 5.103

7.  A case of optic neuritis complicating herpes zoster ophthalmicus in a child.

Authors:  Seong Min Hong; Yun Sik Yang
Journal:  Korean J Ophthalmol       Date:  2010-04-06

8.  Immune Responses to Varicella-Zoster Virus Glycoprotein E Formulated with Poly(Lactic-co-Glycolic Acid) Nanoparticles and Nucleic Acid Adjuvants in Mice.

Authors:  Yunfei Wang; Jialong Qi; Han Cao; Cunbao Liu
Journal:  Virol Sin       Date:  2020-08-05       Impact factor: 4.327

9.  Herpes zoster ophthalmicus in an otherwise healthy 2-year-old child.

Authors:  Marijn Soeteman; Rick P P Willems; Jamiu O Busari
Journal:  BMJ Case Rep       Date:  2012-10-30

10.  Necrotizing fasciitis and streptococcal toxic shock syndrome secondary to varicella in a healthy child.

Authors:  Byung Ok Kwak; Min Jung Lee; Hye Won Park; Min Kyung Song; Sochung Chung; Kyo Sun Kim
Journal:  Korean J Pediatr       Date:  2014-12-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.